Started RU today, and only will only be running RU. Posting updates every 30 days. 3/15/2021
The user started using RU58841 for hair loss, noticing thicker hair within 30 days but stopped due to breathing issues, which they couldn't directly attribute to RU. They later switched to a topical minoxidil and finasteride mix, which stopped shedding but didn't match RU's quick results.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity Finasteride and Topical Minoxidil to Dutasteride and Oral Minoxidil. Is RU58841 still helping?
The user switched from finasteride and topical minoxidil to dutasteride and oral minoxidil, questioning the effectiveness and safety of continuing RU58841. They experienced hair loss improvement initially but are now considering stopping RU58841 due to cost and safety concerns.
community 21M Considering Topical Fin or RU After Oral Minoxidil and Fin Reactions
A 21-year-old male experienced negative side effects from oral finasteride and is considering switching to topical finasteride or RU58841 after using oral minoxidil. He seeks advice on a standard hair loss routine, mentioning peptides, RU58841, and dermarolling.
community Adding Topical Dutasteride on top of Oral Finasteride & Oral Minoxidil (19m)
The user experienced gradual hair thinning since 2021 and tried various treatments including topical minoxidil, rosemary oil, oral finasteride, oral minoxidil, RU58841, and oral dutasteride. They are considering switching to daily finasteride and adding topical dutasteride, tretinoin, and microneedling due to side effects from oral dutasteride.
community 5 year progress on fin/dut and topical/oral minoxidil
The user shared their 5-year hair regrowth journey using oral finasteride, oral dutasteride, topical and oral minoxidil, and a hair transplant. They experienced significant hair improvement without major side effects, although RU58841 was not effective for them.
community Finasteride since November 2024, Minoxidil topical since Jan 2025, oral since Dec 2025. Below baseline after what appeared to be initial progress.
The user has been using finasteride since November 2024, topical minoxidil since January 2025, and oral minoxidil since December 2025, with some experimentation with microneedling and RU58841. Despite initial progress, the user experienced accelerated hairline recession and loss of density in recent months.
community 2 months of minoxidil with 1 and a half months of microneedling, 1 month of ru58 and 10 days of topical minoxidil and finasteride.
The user shared progress pictures after 2 months of minoxidil, 1.5 months of microneedling, 1 month of RU58841, and 10 days of topical minoxidil and finasteride. They discussed their hair loss treatment regimen and results.
Related Research
6 / 6 resultsresearch Hair Growth Effect of DN106212 in C57BL/6 Mouse and Its Network Pharmacological Mechanism of Action
In this study, the alcoholic extract DN106212 from Centipeda minima was shown to be more effective in promoting hair growth in C57BL/6 mice compared to dimethyl sulfoxide and tofacitinib, suggesting its potential as a natural hair growth agent.
research Finasteride inhibits the progesterone-induced spike-wave discharges in a genetic model of absence epilepsy
Finasteride blocks progesterone's effect on absence seizures in rats.
research Surgical and conservative methods of treatment of androgenic alopecia (literature review)
This study examined the current literature on treatments for androgenic alopecia and found that while various methods exist, hair autotransplantation is still considered the gold standard due to its high graft survival and patient satisfaction.
research Vitamins and their derivatives synergistically promote hair shaft elongation ex vivo via PlGF/VEGFR-1 signalling activation
This study found that a combination of vitamins in hair care products promoted hair shaft elongation in a mouse model by activating the PlGF/VEGFR-1 signaling pathway.
research Treatment of androgen excess in females: Yesterday, today and tomorrow
This review discusses the regulation of hair growth, causes of excessive androgen secretion, and current safe solutions for hyperandrogenism manifestations in women but reports no new clinical results.
research Clinical Experience of Professor Ma Shuanquan in Treating Androgenetic Alopecia
In this analysis, Professor Ma Shuanquan attributes androgenetic alopecia to liver, spleen, and kidney dysfunctions and describes a treatment approach using Chinese medicines focused on these organs, suggesting individualization and noting significant therapeutic effects.